Craig Thompson, CEO of Cerevance touches on the NETSseq platform and how it shapes Cerevance's approach to the drug discovery strategy.
Craig Thompson
Advertisement
Articles by Craig Thompson
Craig Thompson, CEO of Cerevance discusses the key scientific and clinical insights that lead to Cerevance's pursuit of Solengepras.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Merck Planning $70 Billion Investment for US Expansion
2
Roundup: FDA Approves Novo Nordisk's Rybelsus and Roche’s Gazyva/Gazyvaro
3
From Advantage to Essential: How Daily Data & AI Alerts Transform Commercial Functions
4
Amazon and WeightWatchers Partner for DTC Weight Loss Medication Offerings
5
